Tolerance associated with cord blood transplantation may depend on the state of host dentritic cells by Law, HKW et al.
Title Tolerance associated with cord blood transplantation maydepend on the state of host dentritic cells
Author(s) Liu, E; Law, HKW; Lau, YL
Citation British Journal Of Haematology, 2004, v. 126 n. 4, p. 517-526
Issued Date 2004
URL http://hdl.handle.net/10722/48652
Rights Creative Commons: Attribution 3.0 Hong Kong License
This is a pre-published version
Tolerance associated with cord blood transplantation may depend on the 
state of host dendritic cells
Running title: Dendritic cells and neonatal tolerance
ENMEI LIU1,2, HELEN KW LAW2, YU-LUNG LAU2
1Division of Respiratory Disorders, Children's Hospital, Chongqing University of Medical 
Sciences, Chongqing; 2Department of Paediatrics & Adolescent Medicine, Faculty of 
Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, 
China.  [E.L., H.K.W.L., Y.L.L.]
Correspondence:
Dr.  Yu-Lung Lau
Department of Pediatrics & Adolescent Medicine
Faculty of Medicine
The University of Hong Kong
Queen Mary Hospital
Pokfulam, Hong Kong, China
Tel:       (852) 2855 4205
Fax:      (852) 2855 1523
E-mail: lauylung@hkucc.hku.hk
1Summary
Allogeneic cord blood (CB) transplantation is associated with less severe GvHD, thought to 
be due to the immaturity of CB T cells, but how T cells interact with host and donor-derived 
dendritic cells (DCs) to initiate GvHD has not been elucidated.  We therefore investigated the 
responses of CB and adult blood CD4+ T cells co-cultured with adult host DCs of different 
maturities.  Primed by adult host DCs, CB and adult blood CD4+ T cells underwent similar 
changes in the expression of CD45RA/45RO, CD25, CD40L and CTLA-4.  However, CB 
CD4+ T cells, when primed by either immature or BCG-treated adult host DCs, produced 
lower IFN- and higher IL-10, which is of regulatory T cell-like cytokine profile, as compared 
to adult blood CD4+ T cells.  On the contrary, LPS-treated adult host DCs significantly up-
regulated IFN- and down-regulated IL-10 production levels from CB CD4+ T cells to that 
from adult blood CD4+ T cells.  The sustained low IFN- and high IL-10 production from CB 
CD4+ T cells co-cultured with adult blood DCs might account for the less severe GvHD 
occurrence after CB transplantation, which could be reversed by LPS-treated adult blood 
DCs.
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2INTRODUCTION
Allogeneic bone marrow transplantation has been used as an effective treatment for various 
malignancies and genetic disorders (Tabbara, 1996; Ikehara, 1998), however, graft-versus-
host disease (GvHD) remains a major complication despite significant advances have been 
made in histocompatability matching and conditioning regimens (Hows et al, 1986).  
Recently, allogeneic umbilical cord blood transplantation is increasingly being used for 
haematopoeitic reconstitution and it has a lower incidence of severe GvHD than bone marrow 
transplantation (Gluckman et al, 1997).  The definitive mechanism for this advantage of cord 
blood is unknown.  Since GvHD is initiated by the direct recognition of alloantigens on 
recipient antigen-presenting cells (APCs) by donor T cells, the most common explanation for 
the low incidence of GvHD after cord blood transplantation is the reduced and naïve T cell 
function in comparison with adult blood T cells.  Cord blood contains higher percentage of 
the naïve CD4+CD45RA+ T cells; lower antigen and mitogen specific T cell proliferation; and 
lower cytokine production on stimulation (Cohen & Madrigal, 1998).  Recently, the tolerant 
nature of cord blood T cells to produce high levels of IL-10 has been suggested as an 
underlying factor in the reduced incidence of GvHD associated with cord blood 
transplantation (Levings et al, 2001; Rainsford & Reen, 2002).
As the professional APCs, dendritic cells (DCs) play a critical role in initiating primary T cell 
response (Steinman, 1991).  Direct presentation of host alloantigens by resident host DCs is 
likely to exert a dominant effect on the activation of donor T cells, resulting in both acute and 
chronic GvHD (Shlomchik et al, 1999).  Through modulating cytokine profile of donor DCs 
or promoting Th2-inducing DCs, granulocyte colony-stimulating-factor decreases acute 
GvHD (Arpinati et al, 2000; Reddy et al, 2000).  Matthews et al (2000) reported that when 
co-culturing cord blood T cells and adult blood T cells with allogeneic adult blood monocyte-
3derived DCs, cord blood T cells have stronger proliferative responses to allogeneic DCs than 
adult blood T cells, sustained expression of CD40L and pro-inflammatory cytokine 
production in comparison with adult blood T cells, and speculated that reduced GvHD in cord 
blood transplantation could be the result of the failure of host APCs to strongly stimulate cord 
blood T cells rather than an innate inability of cord blood T cells to respond effectively to 
alloantigens.
In our previous studies, we not only demonstrated dysfunction of cord blood T cells (Tu et al, 
1999; Tu et al, 2000), but also immaturity of cord blood monocyte and monocyte-derived 
DCs (Liu et al, 2001a; Liu et al, 2001b).  Following these observations, we further 
investigated in this study the interaction of cord blood donor DCs/T cells with adult host 
DCs/T cells to test the hypothesis that the less severe GvHD with cord blood transplantation 
is related to the properties of both cord blood T cells and DCs.  We compared the expansion, 
phenotypic expression and cytokine production between cord blood CD4+ T cells and adult 
blood CD4+ T cells primed by immature and mature adult DCs.  In addition, we investigated 
the effects of cord blood DCs and adult blood DCs on adult blood CD4+ T cells.
4MATERIALS AND METHODS
Isolation of monocytes.  Human umbilical cord blood was obtained from the placentae of 
normal, full-term infants, after the placentae were delivered and separated from the infants, 
with prior written informed consent of their mothers.  The Ethics Committee of the University 
of Hong Kong approved the protocol.  Normal adult blood came form blood donors of Hong 
Kong Red Cross.  All samples were collected in heparinized flasks.  Cord blood mononuclear 
cells (CBMC) and adult peripheral blood mononuclear cells (PBMC) were isolated from 
whole blood by centrifugation, using Ficoll-Hypaque gradients (Pharmacia Biotech, Uppsala, 
Sweden).  Mononuclear cells at the interface were collected, washed threes times, and 
resuspended at 1x108/ml pH 7.2 Hanks/Hepes buffer.  Monocytes were isolated from 
mononuclear cells by positive selection using anti-CD14 conjugated magnetic microbeads 
(Miltenyi Biotec, Bergisch Gladbach, Germany).  Isolated cells from the positive fraction 
were cultured at a density of 1x106 cells/ml in RPMI-1640+10% FCS (Sigma Chemical Co., 
St.Louis, MO), supplemented with 50IU/ml penicillin and 50µg/ml streptomycin.  Cell 
viability, as measured by trypan blue exclusion, was more than 95%.  The purity of 
monocytes was measured by flow cytometry with 85% to 95% of the cells being CD14 
positive.
Isolation of cord blood naïve CD4+ T cells and adult CD4+ T cells.  Untouched cord blood 
CD4+ T cells and adult blood CD4+ T cells were isolated from CBMC and PBMC by negative 
immunomagnetic selection using the CD4+ T cell isolation kit (Miltenyi Biotec, Bergisch 
Gladbach, Germany).
Generation of immature DCs in vitro.  A total of 1x106 monocytes were cultured in the 
presence of IL-4 (10ng/ml; R&D, Minneapolis, USA) and GM-CSF (50ng/ml; R&D, 
5Minneapolis, USA) for 7 days at 37ºC in a humidified atmosphere containing 5% CO2 as in 
our previous study (Liu et al, 2003b).  The cultures were fed with fresh RPMI-1640+10%FCS 
medium and cytokines every three days and cell differentiation was monitored by light 
microscopy.
Generation of mature DCs in vitro. Bacillus Calmette-Guerin mycobacteria (BCG) (50µl, 
Danish strain 1331, Statens Serum Institute, Denmark) and LPS (10µg/ml, Sigma, USA) 
which have been confirmed to promote DC maturation by up-regulation of MHC class II 
molecules and co-stimulatory molecules (Liu et al, 2003a) were added for the last 2 days of 
the immature DCs culture.
Co-cultures of different DCs with cord blood naïve CD4+ T cells and adult CD4+ T cells.  
Freshly isolated cord blood naïve CD4+ T cells and adult CD4+ T cells (1 x 106/ml) were co-
cultured with immature, BCG-treated and LPS-treated adult blood DCs (DC:T cell = 1:10) for 
7 days.  After priming, absolute viable cell counts were obtained by Trypan blue exclusion to 
document T cell expansion.  Cells were collected for phenotypic expression analysis and 
supernatants were stored at -20°C for cytokine assays.
Immunofluorescence staining.  Cord blood naïve CD4+ T cells and adult CD4+ T cells 
primed with different DCs were transferred to microcentrifuge tubes, diluted with 1 ml PBS 
and centrifuged 13,000g for 10 seconds.  The supernatant was removed, and the cell pellet 
was resuspended in the small amount of remaining PBS.  Fluorochrome conjugated antibodies 
at concentrations of 4 µg/106 cells were added and then the cell suspension was incubated for 
15 minutes at 20°C.  After incubation, the cells were diluted in 1 ml of wash solution 
(PBS+0.1% fetal bovine serum +0.1% azide) and after centrifugation and removal of 
6supernatant, the cells were resuspended in 300 µl of the same solution for flow cytometric 
analysis.  FITC, PE and PC5 conjugated isotype controls and CD45RA–FITC, CD45RO-
FITC, CD4-PE antibodies were purchased from Coulter (Miama, Florida, USA).  CD25-FITC 
antibody was purchased from PharMingen (San Diego, CA, USA).  Flow cytometric analysis 
was performed with a COULTER EPICS ELITE Flow Cytometer (Coulter Corporation, 
Miami, Florida, USA).  The machine was optimized daily using standard fluorescence bead 
(Coulter Corporation, Miami, Florida, USA).  Ten thousand events per sample were collected 
into listmode files and analyzed by the WINMDI 2.8 analysis software.
Analysis of CD40L and CTLA-4 expression.  After primed by DCs for 7 days, CD4+ T cells 
were resuspended in fresh RPMI-1640+10% FCS at 1x106/ml and re-stimulated with PMA 
(25ng/ml, Sigma, Saint Louis, Missouri, USA) and ionomycin (1µg/ml, Sigma, Saint Louis, 
Missouri, USA) for 5 hours.  Surface staining of CD40L-PE was performed before the 
intracellular staining (as described below) of CTLA-4-PC5.  Both CD40L-PE and CTLA-4-
PC5 antibodies were purchased from PharMingen (San Diego, CA, USA).
Analysis of IFN- expression.  Briefly, 1x106/ml fresh isolated CBMC/PBMC or live T cells 
after primed by DCs for 7 days were simulated or re-simulated by PMA+ionomycin for 5 
hours.  Brefeldin A (10µg/ml, Sigma, Saint Louis, Missouri, USA) was added after the first 
hour of culture to stop the golgi activities and then for further 4 hours culture.  Intracellular 
staining was performed as described below and IFN--FITC antibody was purchased from 
PharMingen (San Diego, CA, USA).
7Intracellular immunofluorescence staining
In genereal, cells for intracelluar staining were washed with PBS, resuspended in 500µl of 
1xFACS TM Lysing Solution (BD immunocytometry systems, San Jose, CA, USA), then 
vortexed and incubated for 10 min at room temperature.  Cells were washed with PBS and 
centrifuged at 500g for 5 min, then 500µl of 1xFACS Permeabilizing Solution was added.  
Cells were vortexed and incubated for 10 min at room temperature in the dark.  Cells were 
washed by adding PBS containing 0.5% bovine serum albumin (BSA) and 0.1% NaN3, and 
centrifuged for 5 min.  Twenty microlitres of fluorencent-conjugated intracellular antibodies 
were added into cell suspension, vortexed and incubated for 30 min at room temperature in 
the dark.
Detection of IFN-, IL-10, IL-4 production by T cells primed by DCs.  After 7 days culture, 
the supernatants of cord blood and adult blood T cells cocultured with DCs were harvested 
and stored at –20°C.  The levels of IFN-, IL-10, IL-4and were measured by ELISA kits 
(R&D Systems Inc, Minneapolis, USA).  The minimal detection levels of IFN-, IL-10, and 
IL-4 were 15.6pg/ml, 62.5pg/ml and 31.2pg/ml respectively.
Statisical Analysis
All samples were paired and differences between groups analysed by paired Student t test or 
the non-parametric equivalents.  In most cases, data were expressed as mean±SEM.
8RESULTS
The percentages of CD4+CD25+ cells were the same in cord blood CD4+ T Cells and adult
blood CD4+ T cells
The percentages of CD4+CD25+ cells, which represent a population of regulatory T cells 
responsible for inducing tolerance (Sakaguchi et al, 1995; Takahashi et al, 1998; Itoh et al, 
1999), was the same in purified cord blood CD4+ T cells (6±0.8%, n=8) and adult blood CD4+
T cells (7±0.6%, n=4) (Fig 1A).  As in our previous report (Tu et al, 2000), more than 95% 
cord blood CD4+ T cells were CD45RA+ naïve T cells compared to 68% in adult T cells, 
while less than 5% cord blood CD4+ T cells were CD45RO+ memory T cells compared to 
32% in adult CD4+ T cells (Fig 1A).
The percentage of IFN-+ cells from CBMC was reduced as compared to PBMC upon PMA
plus ionomycin stimulation
Freshly isolated CBMC and adult PBMC were incubated in RPMI+10%FCS with 
PMA+ionomycin for 5 hours, then the percentages of IFN-+ cells were detected by 
intracellular cytokine staining (Fig 1B).  Remarkably higher percentage of IFN-+ cells was 
detected in PBMC (33±3%, n=8) than in CBMC (4±0.8%, n=8, p<0.001) (Fig 1C).
Cord blood CD4+ T cells had higher capacity to expand than adult blood CD4+ T cells 
After 7 days of co-culturing with adult blood immature DCs, the cell number did not increase 
significantly in both cord blood (n=10) and adult blood (n=4) CD4+ T cells.  However, when 
primed by BCG-treated and LPS-treated adult blood DCs, there was significantly higher cell 
number in cord blood T cells than that in adult blood T cells (Fig 2A).
9CD45RA/RO expression on cord blood CD4+ T cells and adult blood CD4+ T cell became 
the same after priming with DCs
After co-culturing with immature and BCG-treated adult blood DCs for 7 days, the percentage 
of CD45RA+ cells decreased and the percentage of CD45RO+ cells increased in both cord 
blood CD4+ T cell and adult blood CD4+ T cells.  BCG-treated DCs did not promote further 
differentiation of CD45RA+ cells to CD45RO+ cells in either cord blood or adult blood CD4+
T cells as compared with immature DCs (Fig 2B).  Hence both immature and BCG-treated 
mature DCs can promote maturation but only BCG-treated or LPS-treated mature DCs can 
promote expansion of CD4+ T cells.
BCG-treated DCs induced higher percentage of CD25+ cells in both cord blood and adult 
blood CD4+ T cells
Similar percentages of CD25+ cells were observed in cord blood CD4+ T cells and adult CD4+
T cells after priming with adult blood DCs.  Compared with immature DCs, BCG-treated DCs 
induced significantly higher percentage of CD25+ cells in both cord blood (p=0.0072) and 
adult blood (p=0.0121) CD4+ T cells (Fig 2C).
High surface CD40L expression and intracellular CTLA-4 expression in cord blood naïve 
CD4+ T cells compared with that in adult blood CD4+ T cells after priming with DCs and 
re-stimulated by PMA plus ionomycin
Cord blood CD4+ T cells were co-cultured with immature DCs, BCG-treated or LPS-treated 
DCs for 7 days, and re-stimulated by PMA+ionomycin for 5 hours before the surface staining 
and intracellular staining for CD40L and CTLA-4 respectively.  Preliminary experiments 
showed little cytosolic expression of CD40L and surface expression of CTLA-4 (data not 
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shown).  Hence, subsequent experiments were focused on surface expression of CD40L and 
cytosolic expression of CTLA-4.
After co-culturing with immature or BCG/LPS-treated adult blood DCs, cord blood T cells 
had higher percentage of CD40L+ cells than on adult CD4+ T cells, but did not reach 
statistical significance (Fig 3A).  After priming with immature and BCG-treated adult blood 
DCs, relatively higher expression of CTLA-4 were found in cord blood CD4+ T cells than that 
in adult blood CD4+ T cells, but did not reach statistical significance (Fig 3B).  Compared 
with immature DCs, BCG-treated DCs significantly down-regulated CTLA-4 expression in 
adult blood CD4+ T cells (p=0.0195) but not in cord blood naïve CD4+ T cells.  Whereas, 
LPS-treated DCs significantly down-regulated the percentages of CTLA-4+ cells both in cord 
blood CD4+ T cells (p=0.0134) and adult blood CD4+ T cells (p=0.0042).
Sustained lower IFN- and higher IL-10 production from cord blood CD4+ T cells and as 
compared to adult blood CD4+ T cells was reversed by LPS-treated DCs 
The lower percentage of IFN- positive cells in cord blood than in adult blood T cells co-
cultured with immature DCs became similar in both cord blood and adult blood T cells after 
co-cultured with LPS-treated DCs (Fig 4A).  Immature and BCG-treated DCs induced 
significantly lower IFN- production (Fig 4B) and higher IL-10 (Fig 4C) from cord blood 
CD4+ T cells than that of adult blood CD4+ T cells.  However, primed by LPS-treated DCs, 
similar levels of IFN- and IL-10 production were found in cord blood naïve CD4+ T cells and 
adult CD4+ T cells (Figs 4B & 4C).  Our results showed both cord blood and adult blood 
CD4+ T cells produced little IL-4 after primed by DCs (Fig 4D).
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LPS-treated cord blood DCs induced adult blood CD4+ T cells to produce lower level of 
IFN- and higher level of IL-10 than LPS-treated adult blood DCs
In allogeneic bone marrow transplantation the unusual situation arises in which both host and 
donor-derived DCs are present (Shlomchik et al, 1999).  Our results showed LPS-treated cord 
blood DCs induced significantly lower level of IFN- (Fig 5A) and higher level of IL-10 (Fig 
5B) than LPS-treated adult blood DCs from adult blood CD4+ T cells.  Adult blood CD4+ T 
cells produced little IL-4 after primed by adult or cord blood DCs (Fig 5C).
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DISCUSSION
Less severe GvHD with cord blood transplantation has made cord blood an attractive 
alternative to bone marrow for transplantation.  It is generally accepted that the reduced and 
naïve T cells function of cord blood T cells in comparison with adult blood T cells result in 
the low incidence of GvHD after cord blood transplantation (Cohen & Madrigal, 1998).  In 
freshly isolated CD4+ T cells, we found that cord blood had significantly higher CD45RA+
and significantly lower CD45RO+ cells than adult blood (Fig 1A) and both had about 6% 
CD4+CD25+ T cells which represent a population of regulatory T cells (Sakaguchi et al, 1995; 
Takahashi et al, 1998; Itoh et al, 1999) that are distinct from recently activated CD4+ T cells 
(Ng et al, 2001).  There was no difference in the percentage of CD25+ cells between freshly 
purified cord blood CD4+ T cell and adult CD4+ T cell as reported before (Dieckmann et al, 
2001; Ng et al, 2001).  Similar to the results of Chalmers et al  (1998), we found that upon 
stimulation by PMA and ionomycin, cord blood mononuclear cells had lower percentage of 
IFN-+ producing cells as compared to adult peripheral blood mononuclear cells (Fig 1C) and 
this is related to the more naïve T cells in cord blood than in adult blood (Chalmers et al, 
1998).
Dendritic cells play a critical role in initiating primary T cell response (Steinman, 1991).  Co-
culturing allogeneic host DCs with donor T cells is a physiological model to understand how 
cord blood T cells might respond to alloantigens in the initiation of GvHD (Matthew et al, 
2000).  Consistent with previous study (Matthew et al, 2000), we found that no matter primed 
with immature or BCG-treated/LPS-treated adult DCs, cord blood CD4+ T cells had a higher 
capacity to expand than adult blood CD4+ T cells (Fig 2A) and expressed similar level of 
CD40L (Fig 3A).  Moreover, the percentages of CD45RA+ T cells decreased and CD45RO+ T 
cells increased to similar levels in both cord blood and adult blood CD4+ T cells (Fig 2B).  
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The expression of CD25 and CTLA-4 on cord blood and adult blood CD4+ T cells had no 
difference as well (Fig 2C).  These results suggested that cord blood T cells had stronger 
proliferative response than adult blood T cells to mature allogeneic DCs (Matthews et al, 
2000), and had similar potential as adult blood T cells to undergo maturation and activation 
process.  These results also suggested that although immature and mature DCs had similar 
effect on CD4+ T cell maturation process, mature DCs had higher potential than immature 
DCs to induce T cell proliferation and activation in both cord blood and adult blood.  
The relative amount of T helper (Th) 1-type versus Th2-type cytokines appears to be 
important in determining the extent of GvHD (Ferrara et al, 1996; Blazar et al, 1997).  
Increased expression of IFN- is associated with acute GvHD in both human and 
experimental animal models (Troutt & Kelso, 1993; Dickinson et al, 1994; Szebeni et al, 
1994).  However, as a member of the Th2 cytokine family, IL-10 is the most potent anti-
inflammatory cytokine to inhibit the production of pro-inflammatory cytokines such as IL-1, 
IL-6 and TNF- that are thought to contribute to the development of GvHD (D’Andrea et al, 
1993; Moore et al, 1993).  The relationship between IL-10 production and reduced GvHD is 
evidenced by several publications.  In murine model, IL-10 might prevent the induction of 
GvHD (de La Selle et al, 1998).  Inhibition of GvHD reactivity has also been associated with 
high level of IL-10 production in vivo (Krenger et al, 1994, Rainsford & Reen 2002) 
postulated that the production of IL-10 in abundance maybe the regulator of increased 
tolerance associated with cord blood transplantation.  With this physiological model, we 
further confirmed after priming by immature or BCG-treated adult blood DCs, cord blood 
CD4+ T cells produced not only lower level of IFN- (Fig 3B), but higher level of IL-10 (Fig 
3C) than adult blood CD4+ T cells, whereas IL-4 production levels remained very low in both 
cord blood and adult blood CD4+ T cells (Fig 3D).  This cytokine profile from cord blood 
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CD4+ T cells was similar to that of the regulatory T cell (Tr1) cytokine profile.  Tr1 cells are 
distinct from classical Th1 or Th2 cells in that they produce high levels of IL-10, moderate 
amounts of TGF-, IFN- and IL-5, low IL-2 and no IL-4.  More importantly, Tr1 cells 
suppress immune responses in vitro and in vivo via a mechanism that is partially dependent 
on the production of immunoregulatory cytokines IL-10 and TGF- (Groux et al, 1997; 
Cottrez et al, 2000).  Since IL-10 is clearly an important regulatory cytokine and has been 
implicated in some models of transferable T cell tolerance (Groux et al, 1996), sustained 
higher level of IL-10 production by cord blood CD4+ T cells might induce other donor T cells 
such as cytotoxic T cells to be tolerant, resulting in reduced severe GvHD occurrence after 
cord blood transplantation.  Based on our results, we postulated that, after priming by host 
DCs, cord blood CD4+ T cells were skewed to a Tr1-like profile with high IL-10, medium 
IFN- and no IL-4 production, while adult CD4+ T cells, however, were prone to polarize 
towards Th1 with low IL-10 and high IFN- production.
The direction of T cell polariztion induced by DCs may depend not only on DC lineages, but 
also their method of isolation and maturation (Cella et al, 1999), the ratio of DCs to T cells 
(Tanaka et al, 2000), maturation stage (Kadowaki et al, 2000) or the duration of DC 
activation (Langenkamp et al, 2000).  In humans, monocyte-derived CD11c+ DCs polarize 
naïve T cells predominantly towards a Th1 profile, whereas the CD11c- DC subset induced T 
cells produce Th2 response (Rissoan et al, 1999).  Jonuleit et al (2000) and Dhodapkar et al
(2001) strongly suggested that immature DCs may control peripheral tolerance by inducing 
the differentiation of human Tr1.  Based on our previous experience (Liu et al 2001b; 2003a; 
2003b), we selected monocyte-derived DCs to T cells at a ratio of 1:10 to get high response in 
the co-culture.  Primed by immature DCs, cord blood CD4+ T cells produced higher level of 
IL-10 and lower level of IFN- than adult blood CD4+ T cells.  BCG-treated DCs up-regulated 
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IFN- and down-regulated IL-10 production and CTLA-4 expression from cord blood CD4+ T 
cells but did not reach adult levels.  Although BCG can promote DCs maturation (Thurnher et 
al, 1997; Kim et al, 1999), we documented BCG was not as efficient as LPS to up-regulate 
CD86 and Fas expression, and induce IL-12 production from DCs (Liu et al, unpublished 
data).  We then showed in this present study that LPS-treated adult blood DCs could skew 
cord blood CD4+ T cells to Th1 polarization as their sustained low IFN- and high IL-10 
production was reversed.  LPS has been implicated in the pathogenesis of GvHD (Tutschka, 
1988) and toll-like receptor 4, a major receptor for LPS, is associated to risk of GvHD 
occurrence (Lorenz et al, 2001).  We therefore speculate that LPS might, through activating 
host DCs to stimulate donor T cells, increase the GvHD risk in the clinical setting of gram 
negative bacterial sepsis.  Further elucidation of this pathway may lead to novel strategy to 
decrease the risk of GvHD.
The role of donor DCs on GvHD occurrence has not been elucidated.  G-CSF modulates 
cytokine profile of dendritic cells and decreases GvHD through effect on the donor DCs 
(Reddy et al, 2000).  It is conceivable that transplantation of G-CSF-stimulated peripheral 
blood stem cells does not result in overwhelming acute GvHD because the graft contains 
predominantly Th2-inducing DCs (Arpinati et al, 2000).  Our results indicated that adult 
CD4+ T cells produced similar level of IL-10 but lower level of IFN- after priming by 
immature cord blood DCs as compared by adult blood DCs.  However, LPS-treated cord 
blood DCs, as immature cord blood DCs, induced similarly production low level of IFN- and 
high level of IL-10 production by adult blood CD4+ T cells.  Hence, besides the intrinsic 
skewing of cord blood T cells to produce low level of IFN- and high level of IL-10, cord 
blood DCs could also skew adult blood CD4+ T cells to produce low IFN- and high IL-10.  
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The mechanism of how cord blood DCs might impact on less severe GvHD occurrence after 
cord blood transplantation needs to be studied further.
We concluded that the sustained low IFN- and high IL-10 production from cord blood CD4+
T cells might account for the less severe GvHD occurrence after cord blood transplantation 
but this could be reversed by LPS-treated adult blood DCs.  Clinical use of immature DCs to 
promote Tr1 cell development and strategy to avoid activation of host DCs could have high 
impact on the reduction of GvHD.
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LEGENDS
Fig 1.  Comparison of the percentages of subsets of purified CD4+ T cells (A), IFN-+ cells in 
CBMC and PBMC stimulated by PMA+ionomycin (B,C) between cord blood and 
adult blood.  (A) In freshly isolated cord blood (n=8) and adult blood CD4+ T cells 
(n=4), the percentage of CD4+CD25+ cells which represent regulatory T cells had no 
significant difference (p>0.05).  (B) Stimulated by PMA (25ng/ml) plus ionomycin 
(1µg/ml) for 5 hours, the IFN-+ CBMC can be detected by intracellular cytokine 
staining.  The figure shows a representative flow cytometry analysis of 8 experiments. 
(C) The percentages of IFN-+ cells in CBMC (n=8) was significantly higher than that 
in PBMC (n=8, p<0.001).
Fig 2.  Comparison of absolute count of live T cells (A), the percentages of CD45RA+ and 
CD45RO+ cells (B) and the percentages of CD25+ cells in cord blood (CB) and adult 
blood (AB) CD4+ T cells (C).  (A) Primed by immature or BCG/LPS-treated mature 
DCs for 7 days and stained by trypan blue to exclude dead cells, the live cells were 
counted under microscope.  BCG-treated and LPS-treated mature DCs significantly 
increased cell number of T cells.  Cord blood CD4+ T cells (n=10) had higher potential 
to proliferate compared to adult blood T cells (n=4) after primed by BCG-treated 
(p=0.0032) or LPS-treated DCs (p=0.0129).  (B) Primed by immature or BCG-treated 
mature DCs for 7 days, the percentage of CD45RA+ cells down-regulated and 
CD45RO+ cells up-regulated in cord blood (n=9) and adult blood CD4+ T cells (n=7) 
to similar levels.  The effects of immature and BCG-treated DCs on phenotype 
conversion of cord blood and blood T cells had no difference.  (C) Primed by 
immature or BCG-treated mature DCs, the percentage of CD25+ cells in cord blood 
(n=8) and adult CD4+ T cells (n=5) had no significant difference.  BCG-treated mature 
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DCs had higher capacity than immature DCs to induce CD25+ cell production both in 
cord blood (p=0.0072) and adult blood CD4+ T cells (p=0.0121).
Fig 3.  Comparison of the percentage of CD40L+ cells (A), CTLA-4+ cells (B) and IFN-+
cells (C) in cord blood and adult blood CD4+ T cells primed by DCs for 7days and 
then re-stimulated by PMA (25ng/ml) plus ionomycin (1µg/ml) for 5 hours.  (A) No 
matter primed by immature or mature DCs, the percentage of CD40L+ cells in cord 
blood CD4+ T cells (n=5) was higher than that in adult CD4+ T cells (n=5), but did not 
reach statistical significance.  Compared to immature DCs, mature DCs induced by 
BCG and LPS did not enhance the percentages of CD40L+ cells both in cord blood 
and adult blood CD4+ T cells.  (B) CTLA-4 expression was similar in both cord blood 
and adult CD4+ T cells primed by either immature or LPS-treated DCs.  Compared to 
immature DCs, BCG-treated DCs significantly down-regulated CTLA-4 expression in 
adult blood CD4+ T cells (p=0.0195), while LPS-treated DCs significantly down-
regulated the percentages of CTLA-4+ cells in both cord blood (p=0.0134) and adult 
blood CD4+ T cells (p=0.0042).
Fig 4.  Comparison of percentages of IFN-+ cells (A) and IFN- (B),  IL-10 (C), IL-4 (D) and 
production in the supernatant of cord blood and adult blood T cells primed by adult 
DCs for 7 days and detected by ELISA. (A) Immature DCs induced significantly 
lower IFN-+ cells in cord blood CD4+ T cells (n=14) compared to adult blood CD4+ T 
cells (n=7, p<0.0001), however, BCG-treated and LPS-treated mature DCs induced 
similar level of IFN-+ cells in cord blood and adult blood CD4+ T cells.  (B) When 
primed by immature or BCG-treated DCs, cord blood CD4+ T cells (n=10) produced 
significantly lower level of IFN- than adult blood CD4+ T cells (n=6, p=0.0005 and
p=0.007 respectively).  LPS-treated DCs up-regulated IFN- production by cord blood 
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CD4+ T cells (n=2) to the level by adult CD4+ T cells (n=6). (C) Contrary to IL-10 
production, significantly higher level of IL-10 production was found in cord blood 
CD4+ T cells (n=7) compared to adult CD4+ T cells (n=6, p=0.0262 and p=0.0088) 
when primed by adult immature and BCG-treated DCs respectively.  LPS-treated DCs 
induced similar level of IL-10 production from cord blood (n=6) and adult blood 
CD4+ T cells (n=6). (D) Whether primed by immature or BCG/LPS-treated mature 
DCs, little IL-4 was produced from both cord blood (n=6) and adult blood T cells 
(n=6).
Fig 5.  Comparison of effects of cord blood and adult blood DCs on adult blood CD4+ T cells. 
(A) Adult blood CD4+ T cells produced significantly higher level of IFN- when 
primed by immature or LPS-treated mature adult blood DCs (n=6) than when primed 
by the corresponding cord blood DCs (n=6).  (B) Primed by immature cord blood DCs 
(n=7) or adult blood DCs (n=7), adult blood CD4+ T cells produced similar level of 
IL-10.  Compared to adult blood DCs, both BCG-treated and LPS-treated cord blood 
DCs induced significantly higher levels of IL-10 production from adult blood CD4+ T 
cells.  (C) Whether primed by immature or BCG/LPS-treated mature cord blood or 
adult blood DCs, adult blood CD4+ T cells produced little IL-4.
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